VEGFC and inflammatory bowel disease: Our findings that systemic application of the F8–VEGF-C fusion protein in db/db mice resulted in a significantly increased density of lymphatic vessels in the granulation tissue are in agreement with our previous studies of F8–VEGF-C in inflammatory bowel disease, chronic skin inflammation, chronic colitis, and atherosclerosis [43,44,74].